Works matching AU Tagliamento, Marco
Results: 37
Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 652, doi. 10.3390/cancers17040652
- By:
- Publication type:
- Article
Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1566, doi. 10.3390/jcm8101566
- By:
- Publication type:
- Article
Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1011, doi. 10.3390/jcm8071011
- By:
- Publication type:
- Article
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00544-7
- By:
- Publication type:
- Article
EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, p. 1, doi. 10.1038/s41698-024-00518-9
- By:
- Publication type:
- Article
Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 6, p. 832, doi. 10.3390/cells12060832
- By:
- Publication type:
- Article
Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved Test.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 12, p. 1901, doi. 10.3390/cells11121901
- By:
- Publication type:
- Article
Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer.
- Published in:
- Clinical Medicine Insights: Oncology, 2020, v. 14, p. 1, doi. 10.1177/1179554920931816
- By:
- Publication type:
- Article
Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer.
- Published in:
- Clinical Medicine Insights: Oncology, 2020, v. 14, p. 1, doi. 10.1177/1179554920931816
- By:
- Publication type:
- Article
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer.
- Published in:
- Clinical & Experimental Metastasis, 2019, v. 36, n. 5, p. 449, doi. 10.1007/s10585-019-09984-z
- By:
- Publication type:
- Article
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01427-8
- By:
- Publication type:
- Article
Emerging issues related to COVID-19 vaccination in patients with cancer.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 255, doi. 10.1007/s40487-021-00157-1
- By:
- Publication type:
- Article
VISTA: A Promising Target for Cancer Immunotherapy?
- Published in:
- ImmunoTargets & Therapy, 2021, v. 10, p. 185, doi. 10.2147/ITT.S260429
- By:
- Publication type:
- Article
Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients.
- Published in:
- Breast Cancer: Basic & Clinical Research, 2020, p. 1, doi. 10.1177/1178223420954179
- By:
- Publication type:
- Article
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer.
- Published in:
- Lung, 2024, v. 202, n. 2, p. 197, doi. 10.1007/s00408-024-00675-5
- By:
- Publication type:
- Article
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer.
- Published in:
- Frontiers in Immunology, 2020, p. 1, doi. 10.3389/fimmu.2020.00125
- By:
- Publication type:
- Article
Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 12, p. 1851, doi. 10.1007/s11912-022-01335-8
- By:
- Publication type:
- Article
Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 1, p. 224, doi. 10.3390/ijms25010224
- By:
- Publication type:
- Article
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 5, p. 2625, doi. 10.3390/ijms22052625
- By:
- Publication type:
- Article
RETRACTED ARTICLE: Can baseline endocrinological examination and thyroid ultrasound predict the development of thyroid disease in immunotherapy-treated patients? Results from a prospective, single-center, open-label study.
- Published in:
- Endocrine (1355008X), 2020, v. 69, n. 1, p. 233, doi. 10.1007/s12020-019-01854-8
- By:
- Publication type:
- Article
Serum levels of VCAM‐1 are associated with survival in patients treated with nivolumab for NSCLC.
- Published in:
- European Journal of Clinical Investigation, 2022, v. 52, n. 1, p. 1, doi. 10.1111/eci.13668
- By:
- Publication type:
- Article
Italian survey on managing immune checkpoint inhibitors in oncology during COVID‐19 outbreak.
- Published in:
- European Journal of Clinical Investigation, 2020, v. 50, n. 9, p. 1, doi. 10.1111/eci.13315
- By:
- Publication type:
- Article
ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentarium.
- Published in:
- Expert Opinion on Pharmacotherapy, 2020, v. 21, n. 6, p. 679, doi. 10.1080/14656566.2020.1724283
- By:
- Publication type:
- Article
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer.
- Published in:
- Expert Opinion on Pharmacotherapy, 2018, v. 19, n. 18, p. 2055, doi. 10.1080/14656566.2018.1540591
- By:
- Publication type:
- Article
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer.
- Published in:
- Expert Opinion on Pharmacotherapy, 2018, v. 19, n. 17, p. 1969, doi. 10.1080/14656566.2018.1536746
- By:
- Publication type:
- Article
Performance of the OncomineTM Lung cfDNA Assay for Liquid Biopsy by NGS of NSCLC Patients in Routine Laboratory Practice.
- Published in:
- Applied Sciences (2076-3417), 2020, v. 10, n. 8, p. 2895, doi. 10.3390/app10082895
- By:
- Publication type:
- Article
The FLARE Score and Circulating Neutrophils in Patients with Cancer and COVID-19 Disease.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2974, doi. 10.3390/cancers16172974
- By:
- Publication type:
- Article
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143412
- By:
- Publication type:
- Article
The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3117, doi. 10.3390/cancers13133117
- By:
- Publication type:
- Article
Update on the Management of Breast Cancer during Pregnancy.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3616, doi. 10.3390/cancers12123616
- By:
- Publication type:
- Article
Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1125, doi. 10.3390/cancers12051125
- By:
- Publication type:
- Article
CD34<sup>+</sup>DNAM-1<sup>bright</sup>CXCR4<sup>+</sup> haemopoietic precursors circulate after chemotherapy, seed lung tissue and generate functional innate-like T cells and NK cells.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1332781
- By:
- Publication type:
- Article
Comment on "Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta‑analysis".
- Published in:
- 2022
- By:
- Publication type:
- Letter
Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 2, p. 269, doi. 10.1007/s10549-021-06436-9
- By:
- Publication type:
- Article
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 8, p. 1351, doi. 10.1007/s00262-019-02367-z
- By:
- Publication type:
- Article
Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 7, p. 1011, doi. 10.3390/jcm8071011
- By:
- Publication type:
- Article
Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women.
- Published in:
- Breast Cancer: Targets & Therapy, 2021, v. 13, p. 341, doi. 10.2147/BCTT.S274283
- By:
- Publication type:
- Article